Comparison between Amar Remedies IPO and Infrastructure Development Finance IPO.
Amar Remedies IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Infrastructure Development Finance IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Amar Remedies IPO is up to ₹42.00 Cr whereas the issue size of the Infrastructure Development Finance IPO is up to ₹1,372.24 Cr. The final issue price of Amar Remedies IPO is ₹28.00 per share and of Infrastructure Development Finance IPO is ₹34.00 per share.
| Amar Remedies IPO | Infrastructure Development Finance IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹24.00 per share | ₹29.00 per share |
| Issue Price (Upper) | ₹28.00 per share | ₹34.00 per share |
| Issue Price (Final) | ₹28.00 per share | ₹34.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 1,50,00,000 shares | 12,00,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹42.00 Cr | up to ₹408.00 Cr |
| OFS Issue Size | 0 shares | 28,36,00,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹964.24 Cr |
| Issue Size Total | 1,50,00,000 shares | 40,36,00,000 shares |
| Issue Size Total (Amount) | up to ₹42.00 Cr | up to ₹1,372.24 Cr |
Amar Remedies IPO opens on Aug 25, 2005, while Infrastructure Development Finance IPO opens on Jul 15, 2005. The closing date of Amar Remedies IPO and Infrastructure Development Finance IPO is Aug 31, 2005, and Jul 22, 2005, respectively.
Amar Remedies IPO P/E ratio is 4.63, as compared to Infrastructure Development Finance IPO P/E ratio of .
| Amar Remedies IPO | Infrastructure Development Finance IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 42.67 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 4.63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹73.26 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.05 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 27.47 | 16.10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Amar Remedies IPO Retail Individual Investors (RII) are offered 52,50,000 shares while in Infrastructure Development Finance IPO retail investors are offered 52,50,000 shares. Qualified Institutional Buyers (QIB) are offered 75,00,000 shares in Amar Remedies IPO and 20,18,00,000 shares in Infrastructure Development Finance IPO.
| Amar Remedies IPO | Infrastructure Development Finance IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 75,00,000 shares | 20,18,00,000 shares |
| NII | 22,50,000 shares | 6,05,40,000 shares |
| RII | 52,50,000 shares | 14,12,60,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 1,50,00,000 shares | 40,36,00,000 shares |
Amar Remedies IPO subscribed in total, whereas Infrastructure Development Finance IPO subscribed .
